H2AZ1 and Miyoshi myopathy: To assess the anti-MM and inflammatory role for histones in vivo, NSG-mice receiving ARP1 and treated with recombinant H2AZ showed that administration of H2AZ was associated with a remarkable delay in the progression of MM (Fig. 4c-e).